Department of Medicine, Federal Medical Centre, Asaba, Delta State, Nigeria. Email:
Department of Medicine, University of Benin Teaching Hospital, Benin City, Edo State, Nigeria.
West Afr J Med. 2023 Jul 28;40(7):711-719.
Vitiligo is an acquired pigmentary disorder with significance among dark skinned individuals.
The objective of this study is to correlate the Vitiligo Impact Scale with the DLQI as tools in assessing patients with vitiligo in Benin City, Nigeria.
This was a cross sectional analytical study among adult vitiligo patients who attended the dermatology clinic between February, 2018 and June, 2019. Both patients and controls were recruited consecutively. Data was obtained using a three-section interviewer administered questionnaire. Data was analyzed using uni, bivariate analysis and the Pearson correlation coefficient.
A total of 80 patients were recruited, 40 each for study group and control. The mean age of the study group was 38.43 ±12.94 while the control was 37.25±13.31. The DLQI mean score for the vitiligo group was 3.65±5.57, while the control group was 0.35 ±1.10 (p = 0.001). The mean VIS-22 scale was 12.00±9.89 for the vitiligo patients. The DLQI identified about half (52.5%) of the vitiligo patients with impaired Qol while the VIS-22 identified 70% of vitiligo patients with impaired Qol. The most affected domains were feelings and symptoms for DLQI and anxiety for VIS-22. Both scales indicated significant impact on QoL in patients with involvement of exposed aspects of the body. There is a strong positive correlation between DLQI and Vis-22.
The vitiligo Impact Scale VIS-22 identified more persons with impaired QoL than DLQI.
白癜风是一种获得性色素障碍性疾病，在深色皮肤人群中意义重大。
本研究旨在将白癜风影响量表（VIS-22）与皮肤病生活质量指数（DLQI）相关联，作为评估尼日利亚贝宁城白癜风患者的工具。
这是一项横断面分析研究，纳入了 2018 年 2 月至 2019 年 6 月期间在皮肤科诊所就诊的成年白癜风患者。患者和对照组均连续招募。使用三节访谈员管理的问卷获得数据。使用单变量、双变量分析和 Pearson 相关系数进行数据分析。
共招募了 80 名患者，研究组和对照组各 40 名。研究组的平均年龄为 38.43±12.94 岁，而对照组为 37.25±13.31 岁。白癜风组的 DLQI 平均得分为 3.65±5.57，而对照组为 0.35±1.10（p=0.001）。白癜风患者的 VIS-22 平均得分为 12.00±9.89。DLQI 确定了大约一半（52.5%）的白癜风患者生活质量受损，而 VIS-22 确定了 70%的白癜风患者生活质量受损。DLQI 中受影响最大的领域是情绪和症状，而 VIS-22 则是焦虑。两个量表都表明，在身体暴露部位受累的患者中，生活质量受到显著影响。DLQI 和 Vis-22 之间存在很强的正相关。
白癜风影响量表（VIS-22）比 DLQI 识别出更多生活质量受损的患者。
